Colestid and Regional enteritis for Men aged 40-49 (a phase IV clinical study of FDA data)

Summary:

Regional enteritis is found for men aged 40-49 who take Colestid (colestipol hydrochloride). This study is created by eHealthMe based on reports of 81 men aged 40-49 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Colestid when people have Regional enteritis
Top conditions
Top co-used drugs
Top other side effects

On Jun, 09, 2026

81 men aged 40-49 reported to have side effects when taking Colestid.
Among them, 12 people (14.81%) have Regional enteritis

What is Colestid?

Colestid has active ingredients of colestipol hydrochloride. It is often used in irritable bowel syndrome. eHealthMe is studying from 2,233 Colestid users. Check the latest studies of Colestid.

What is Regional enteritis?

Regional enteritis (a serious chronic and progressive inflammation of the ileum producing frequent bouts of diarrhoea with abdominal pain and nausea) is found to be associated with 2,126 drugs and 2,081 conditions by eHealthMe. Check the latest studies of Regional enteritis.

Number of reports submitted per year:

Could Colestid cause Regional enteritis in men aged 40-49?

Severity of Regional enteritis

n/a

How people recovered from Regional enteritis

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Pain: 6 people, 50.00%
Insomnia (sleeplessness): 6 people, 50.00%
Cellulitis (infection under the skin): 6 people, 50.00%
Erection Problems: 2 people, 16.67%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 6 people, 50.00%
General Physical Health Deterioration (weak health status): 1 person, 8.33%
Drug Level Decreased: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Colestid and have Regional enteritis?

- Check whether Regional enteritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Colestid and Regional enteritis

How the study uses the data?

The study is based on (applicable) gender, age, colestipol hydrochloride (the active ingredients of Colestid) and Colestid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.